---
title: ACN Newswire – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services Targeting New Diagnostic Tests and Improved Drug Development
description: "PERTH, W. AUSTRALIA, Feb 12, 2018 – (ACN Newswire) – MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a strategic alliance with CPR Pharma Services (CPR), targeting the high growth area of clinical trials and related research, with an offer to acquire 10% of CPR’s share capital through the issue of 4 million PIQ shares."
---

[News & Media ](https://www.proteomics.com.au/news-media)

# [ACN Newswire – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services Targeting New Diagnostic Tests and Improved Drug Development](https://www.proteomics.com.au/news-media/acn-newswire-proteomics-international-announces-strategic-alliance-and-investment-in-cpr-pharma-services-targeting-new-diagnostic-tests-and-improved-d-1754983867629)

 Written by [Proteomics](https://www.proteomics.com.au/news-media/author/proteomics) | Feb 11, 2018 6:00:00 PM

PERTH, W. AUSTRALIA, Feb 12, 2018 – (ACN Newswire) – MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a strategic alliance with CPR Pharma Services (CPR), targeting the high growth area of clinical trials and related research, with an offer to acquire 10% of CPR’s share capital through the issue of 4 million PIQ shares.

Article: [Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services Targeting New Diagnostic Tests and Improved Drug Development](https://www.acnnewswire.com/press-release/english/41414/)

[View full post](https://www.proteomics.com.au/news-media/acn-newswire-proteomics-international-announces-strategic-alliance-and-investment-in-cpr-pharma-services-targeting-new-diagnostic-tests-and-improved-d-1754983867629)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Proteomics"
  },
  "dateModified" : "2025-08-12T09:39:51.498Z",
  "datePublished" : "2018-02-11T18:00:00Z",
  "headline" : "ACN Newswire – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services Targeting New Diagnostic Tests and Improved Drug Development",
  "image" : {
    "@type" : "ImageObject",
    "height" : 60,
    "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
    "width" : 60
  },
  "mainEntityOfPage" : "https://www.proteomics.com.au/news-media/acn-newswire-proteomics-international-announces-strategic-alliance-and-investment-in-cpr-pharma-services-targeting-new-diagnostic-tests-and-improved-d-1754983867629",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News & Media"
  }
}
```